CWA Asset Management Group LLC reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,971 shares of the biopharmaceutical company’s stock after selling 433 shares during the period. CWA Asset Management Group […]
CWA Asset Management Group LLC reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,971 shares of the biopharmaceutical company’s stock after selling 433 shares during the period. CWA Asset Management Group […]
Premier Fund Managers Ltd reduced its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,864 shares of the biopharmaceutical company’s stock after selling 800 shares during the period. Premier […]
Premier Fund Managers Ltd lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,864 shares of the biopharmaceutical company’s stock after selling 800 shares during the quarter. Premier Fund Managers Ltd’s holdings in Gilead Sciences […]